Polythioaminals and Uses Thereof

US2017049902A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017049902-A1
Application numberUS-201514830251-A
CountryUS
Kind codeA1
Filing dateAug 19, 2015
Priority dateAug 19, 2015
Publication dateFeb 23, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Polythioaminal polymers are made from hexahydrotriazine precursors and dithiol precursors. The precursors are blended together and subjected to mild heating to make the polymers. The polymers have the general structure wherein each R 1 is independently an organic or hetero-organic group, each R 2 is independently a substituent having molecular weight no more than about 120 Daltons, X and Z are each a sulfur-bonded species, at least one of X and Z is not hydrogen, and n is an integer greater than or equal to 1. X and Z may be hydrogen or a functional group, such as a thiol-reactive group. The reactive thiol groups of the polythioaminal may be used to attach thiol-reactive end capping species. By using water soluble or water degradable dithiols, such as polyether dithiols, water soluble polythioaminals may be made. Some such polymers may be used to deliver therapeutics with non-toxic aqueous degradation products.

First claim

Opening claim text (preview).

1 . A polymer having the general structure wherein each R 1 is independently an organic or hetero-organic species, each R 2 is independently a substituent having a molecular weight no more than about 120 Daltons, X and Z are each a sulfur-bonded species, at least one of X and Z is not hydrogen, and n is an integer greater than or equal to 1. 2 . The polymer of claim 1 , wherein X is a biologically active species. 3 . The polymer of claim 1 , wherein X is a peptide species. 4 . The polymer of claim 3 , wherein each instance of R 1 is a polymer. 5 . The polymer of claim 3 , wherein at least one instance of R 1 is polyethylene glycol. 6 . The polymer of claim 1 , wherein each instance of R 2 is a methyl group. 7 . The polymer of claim 1 , wherein X is selected from the group consisting of hydrogen, an alkane thiol, an aromatic thiol, a peptide, a thio-acid, a nucleotide, and combinations thereof. 8 . The polymer of claim 1 , wherein each instance of R 1 is the same species. 9 . The polymer of claim 1 , wherein the polymer is a random copolymer. 10 . The polymer of claim 1 , wherein X is a species selected from the group consisting of a cargo, a linking group, a medicine, a functional species, a polymerization starter, a chemical species capable of initiating depolymerization, and combinations thereof. 11 . A polymer comprising a repeating unit with the following structure: and a segment with the following structure: wherein R 1 is an organic or hetero-organic species, R 2 is a substituent having a molecular weight no more than about 120 Daltons, X is a linking group covalently bonded to a sulfur atom, and K is any radical suitable for bonding to X. 12 . The polymer of claim 11 , wherein X is selected from the group consisting of hexyl, dihydroxybutyl, and polyethylene glycol. 13 . The polymer of claim 12 , comprising a segment with the following structure: wherein Z is a therapeutic agent. 14 . The polymer of claim 13 , wherein the therapeutic agent is selected from the group consisting of a peptide, a thio-acid, a nucleotide, and combinations thereof. 15 . The polymer of claim 14 , wherein the polymer has a weight-average molecular weight of at least about 10,000 Daltons. 16 . The polymer of claim 11 , comprising a segment with the following structure: wherein Z is a species selected from the group consisting of an alkane thiol, an aromatic thiol, a peptide, a thio-acid, a nucleotide, and combinations thereof. 17 . The polymer of claim 12 , comprising a segment with the following structure: wherein Z is a species selected from the group consisting of a cargo, a medicine, a chemical species capable of initiating depolymerization, and combinations thereof. 18 . A method of forming a material, comprising: mixing an N-substituted hexahydrotriazine with a dithiol to form a first mixture; and heating the first mixture to form a polythioaminal polymer, wherein the substituent bonded to one or more of the nitrogen atoms of the N-substituted hexahydrotriazine forms a hydride that is volatile at temperatures less than 200° C. 19 . The method of claim 18 , comprising adding a thiol-reactive material to the polythioaminal polymer to form a second mixture, and heating the second mixture to form a modified polythioaminal polymer. 20 . The method of claim 19 , wherein the thiol-reactive material comprises a species that is a cargo, a linking group, a medicine, a functional species for further modification after construction of the end-modified polythioaminal polymer, a polymerization starter, a chemical species capable of initiating depolymerization, and combinations thereof. 21 . The method of claim 18 , comprising adding a solvent to the N-substituted hexahydrotriazine prior to mixing with the dithiol. 22 . The method of claim 19 , wherein the modified polythioaminal polymer is a therapeutic agent.

Assignees

Inventors

Classifications

  • Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links · CPC title

  • Polymers modified by chemical after-treatment · CPC title

  • Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)} · CPC title

  • Human Necessities · mapped topic

  • Polymers containing sulfur · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017049902A1 cover?
Polythioaminal polymers are made from hexahydrotriazine precursors and dithiol precursors. The precursors are blended together and subjected to mild heating to make the polymers. The polymers have the general structure wherein each R 1 is independently an organic or hetero-organic group, each R 2 is in…
Who is the assignee on this patent?
IBM
What technology area does this patent fall under?
Primary CPC classification A61K47/48215. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Feb 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).